Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
Open Access
- 27 October 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (10) , 1724-1730
- https://doi.org/10.1038/sj.bjc.6605371
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)British Journal of Cancer, 2007
- Detection of Mutant BRAF Alleles in the Plasma of Patients with Metastatic MelanomaThe Journal of Molecular Diagnostics, 2007
- Utility of Circulating B-RAF DNA Mutation in Serum for Monitoring Melanoma Patients Receiving BiochemotherapyClinical Cancer Research, 2007
- Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patientsInternational Journal of Cancer, 2007
- Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung CancerClinical Cancer Research, 2006
- Effects of Prolonged Storage of Whole Plasma or Isolated Plasma DNA on the Results of Circulating DNA Quantification AssaysJNCI Journal of the National Cancer Institute, 2005
- Loitering with Intent: New Evidence for the Role of BRAF Mutations in the Proliferation of Melanocytic LesionsJournal of Investigative Dermatology, 2004
- Mutations of the BRAF gene in human cancerNature, 2002
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994